Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

A large body of evidence indicates the existence of a complex pathophysiological
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …

Objectives To evaluate malignancies and their associations with baseline risk factors and
cardiovascular risk scores with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in …

Atrial fibrillation (AF) and coronary artery disease (CAD) are highly prevalent cardiovascular
conditions. The coexistence of both diseases is common as they share similar risk factors …

Despite improvements in cancer survival, cancer therapy–related cardiovascular toxicity has
risen to become a prominent clinical challenge. This has led to the growth of the burgeoning …

Cardiovascular disease (CVD) and cancer are among the leading causes of morbidity and
mortality globally, and these conditions are increasingly recognized to be fundamentally …

Background This study aims to quantify Black–White inequities in cardiovascular disease
(CVD) mortality among US survivors of 18 adult-onset cancers and the extent to which these …

Background Patients with myeloproliferative neoplasms (MPNs), essential thrombocythemia
(ET), polycythemia vera (PV), and myelofibrosis (MF), have increased risk of cardiovascular …

Cancer patients have an increased risk of cardiovascular disease and, notably, a significant
prevalence of acute coronary syndrome (ACS). It has been shown that an elevated presence …

Abstract Background and Objectives An increased risk of cardiovascular and metabolic
diseases (CVMDs) among patients with cancer suggests a potential link between CVMD …